Skip to content

Cohort study, 1996

Does lisuride maleate, a dopamine medication, reduce PMS symptoms?

Symptoms improved significantly, with headaches dropping from 85.7% to 20% and other symptoms also improving. However, this was a small study with no control group, so we cannot be sure how much improvement came from the drug versus placebo.

Early or limited evidence 35 women aged 19-35 with PMS diagnosis

What they did

35 women aged 19-35 with PMS and no other gynecological disorders were treated with lisuride maleate 0.3 mg daily (split into 3 doses) for 3 months. Researchers measured symptom severity and hormone levels before and after treatment.

What they found

All measured symptoms improved significantly: headaches from 85.7% to 20%, breast pain from 91.4% to 25%, bloating from 74.2% to 40%, lower leg swelling from 85.7% to 30%, and leg pain from 61% to 34%. Hormone levels showed small changes in FSH, progesterone, and prolactin.

What it means for you

Lisuride maleate produced large symptom reductions. However, without a control group we cannot know if improvements came from the drug or from placebo or time alone. Adverse events were reported by 20 patients, and 1 withdrew early due to fatigue and headache. Hormone levels were only measured at one time point, so it is unclear how hormones actually changed.

85.7% to 20%

headache reduction

91.4% to 25%

breast pain reduction

74.2% to 40%

bloating reduction

About the study

Original title
[Treatment of premenstrual tension syndrome (PMS) with lisuride maleate]
Authors
López-Rosales C, Aguilar-Guerrero JA, García-Moreno L
Journal
Ginecologia y obstetricia de Mexico
Year
1996
Study design
Cohort study
Participants
35
What was tested
Lisuride maleate 0.3 mg daily for 3 months (dopamine receptor agonist)

Topics